DNA

www.companiesandmarkets.com: Genentech Inc - PharmaVitae Profile - 09/03 - 12:01 PM ET

Genentech dangles cash carrot for employees: TAKEOVER BID SPARKS RETENTION OFFER - 08/22 - 05:26 PM ET

Genentech retention plan to cost $371 million - 08/21 - 09:01 PM ET

The US FDA to Present at IBC's Global Follow-On Biologics Conference - 08/21 - 09:04 AM ET

Genentech considers Roche's proposal as undervaluing the company - 08/15 - 11:25 AM ET

Genentech: rejects Roche bid - 08/14 - 12:39 PM ET

Xinhua world economic news summary at 0430 GMT, Aug.14 - 08/14 - 12:29 AM ET

Genentech Special Committee Rejects Roche's $43.7B Buyout Bid As Too Low - 08/13 - 11:16 PM ET

Genentech rebuffs Roche bid - 08/13 - 04:40 PM ET

Genentech rejects Roche's $43.7 billion bid - 08/13 - 04:39 PM ET

U.S. biotech company rejects Swiss buyoff bid - 08/13 - 01:46 PM ET

Genentech Special Committee of Independent Directors Responds to Roche Proposal - 08/13 - 09:33 AM ET

Genentech Hits New High In Pre-Market - 08/11 - 09:28 AM ET

Genentech (DNA) NewsBite - DNA Hits 52-Week High - 08/08 - 02:39 AM ET

Tolerx's partner Genentech initiates Phase I monoclonal antibody trial - 08/06 - 11:33 AM ET

ONN.tv Report: Whole Foods Earnings Fall Short of Expectations - 08/06 - 10:24 AM ET

Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial - 08/05 - 08:00 AM ET

DNA: To Present At IBC Life Sciences DDT 2008 Conference @ 14:20 ET [delayed] - 08/04 - 12:53 PM ET

Research and Markets: 2008 Report Provides All the Information You Require To Better Understand Genentech and Its Partnering Interests and Activities over the Past Five Years - 07/27 - 08:05 PM ET

Genentech Forms Special Committee of Independent Directors to Review Roche Proposal - 07/24 - 06:30 PM ET

Page 1 of 15     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index